Molecular Regulation of Vascular Calcification in Diabetes
Molecular Regulation of Vascular Calcification in Diabetes
批准号:
10421252
负责人:
Yabing Chen
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-10-01 至 2023-09-30
关键词:
ARNTL geneAffectAnimal ModelAnimalsAortaArteriesBlood VesselsCardiovascular systemCell physiologyCircadian DysregulationCircadian RhythmsClinicalComplicationComplications of Diabetes MellitusDevelopmentDiabetes MellitusDiabetic AngiopathiesDiabetic mouseDisease ProgressionDoseEchocardiographyFOXO1A geneGenesHealthHigh Fat DietHyperglycemiaIn VitroKnowledgeLipidsMass Spectrum AnalysisMediatingMilitary PersonnelMolecularMorbidity - disease rateMusOutcomeOutcome StudyOxidative StressPathogenesisPathologicPhysiologicalPost-Translational Protein ProcessingPrevention therapyProteinsProteomicsProto-Oncogene Proteins c-aktRegulationReportingRoleSignal TransductionSmooth Muscle MyocytesStreptozocinTimeUnited States Department of Veterans AffairsUp-RegulationVascular DiseasesVascular Smooth MuscleVascular calcificationVeteranscalcificationcircadiancircadian pacemakercircadian regulationdiabeticdiabetic cardiomyopathyfeedingimprovedin vivoinsightmilitary veteranmortalitymouse modelnovelnovel strategiesnovel therapeuticstool
中文摘要
血管钙化和僵硬是糖尿病血管疾病的特征,糖尿病血管疾病是一种常见的心血管疾病
导致退伍军人人群发病率和死亡率增加的并发症。退伍军人事务部
糖尿病试验证明,退伍军人的血管钙化增加,但降脂
他汀类药物未能抑制疾病的进展。生物钟被打乱是军队中常见的问题
人员,这影响到我们的许多退伍军人。昼夜节律异常与
加重了糖尿病心血管疾病。然而,昼夜节律异常在加速中的作用
糖尿病血管病变的发病机制尚不清楚。因此,当前的应用程序旨在了解
糖尿病患者的正常昼夜节律紊乱如何影响血管钙化和僵硬?
将填补尚未填补的科学空白。糖尿病通常以高血糖和氧化应激为特征,
已知它们可以促进蛋白质O-GlcN酰化,这是一种关键的翻译后蛋白质修饰,调节
无数的细胞过程。我们已经证明,在血管平滑肌细胞(VSMC)中,升高的O-
GlcN酰化/AKT/FOXO信号诱导主要钙化因子Runx2的表达,从而
促进VSMC钙化。在初步研究中,我们发现了Runx2的时间振荡
与关键的昼夜节律调节因子BMAL1一起在体内和体外的小鼠主动脉和VSMC中表达。在……里面
糖尿病小鼠动脉,O-GlcN酰化升高和BMAL1表达增加,这是
与Runx2的上调有关。此外,利用BMAL1缺陷的VSMC,我们确定了一个
BMAL1依赖信号对VSMC O-GlcN酰化的致病调控因此,我们假设
异常昼夜节律通过O-GlcN酰化促进糖尿病患者的血管钙化-
调节的FOXO/Runx2信号轴。使用我们新生成的可诱导的SMC特异性OGT和BMAL1
删除小鼠模型,该提案将揭示血管生物钟和O-O-1的新致病作用
GlcN酰化在调节糖尿病血管钙化中的作用;并描绘了潜在的分子
机械装置。拟议研究的结果将增进我们对基本
糖尿病血管钙化的发病机制,这应该提供重要的
对开发成功的血管疾病治疗方法的临床意义的分子洞察
生物钟异常和O-GlcN酰化增加。
英文摘要
Vascular calcification and stiffness are hallmarks of diabetic vascular disorder, a prevalent cardiovascular
complication that leads to increased morbidity and mortality in the Veteran's population. The Veterans Affairs
Diabetes Trial has documented that vascular calcification was elevated in the Veterans, but the lipid-lowering
statins failed to inhibit the disease progression. Disrupted circadian clock is a common issue in military
personnel, which affects many of our Veterans. Abnormal circadian rhythm has been associated with
exacerbated diabetic cardiovascular disease. However, the role of abnormal circadian rhythm in accelerating
pathogenesis of diabetic vascular disease is not clear. Therefore, the current application aims to understand
how disruption of normal circadian rhythms may affect vascular calcification and stiffness in diabetes, which
would fill the unmet scientific gaps. Diabetes is often featured with both hyperglycemia and oxidative stress,
which are known to promote protein O-GlcNAcylation, a key posttranslational protein modification that regulates
numerous cellular processes. We have shown that in vascular smooth muscle cells (VSMC), elevated O-
GlcNAcylation/AKT/FOXO signaling induces the expression of the master calcification factor, Runx2, thus
promoting VSMC calcification. In preliminary studies, we uncovered a time-of-day oscillation of Runx2
expression along with BMAL1, the key circadian regulator, in mouse aortas in vivo and in VSMC in vitro. In
diabetic mouse arteries, elevation of O-GlcNAcylation and increased expression of BMAL1 were identified, which
was associated with upregulation of Runx2. Furthermore, using BMAL1 deficient VSMC, we determined a
causative regulation of O-GlcNAcylation in VSMC by BMAL1-dependent signals. Therefore, we hypothesize
that “Abnormal circadian rhythm promotes vascular calcification in diabetes through O-GlcNAcylation-
regulated FOXO/Runx2 signaling axis.” With our newly generated inducible SMC-specific OGT and BMAL1
deletion mouse models, the proposal will uncover a novel causative role of vascular circadian clock and O-
GlcNAcylation in regulating vascular calcification in diabetes; and delineate the underlying molecular
mechanisms. Outcomes from the proposed studies will advance our knowledge in understanding of the basic
mechanisms underlying pathogenesis of vascular calcification in diabetes, which should provide important
molecular insights into clinical implications in the developing successful therapy for vascular disease featuring
abnormal circadian clock and increased O-GlcNAcylation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein Arginine Methylation in Vascular Smooth Muscle Cell Phenotypic Modulation and Calcification
-
批准号:10734531
-
项目类别:
-
资助金额:$71.4万
-
财政年份:2023
-
负责人:Yabing Chen
-
依托单位:
Novel regulation of vascular dementia
-
批准号:10716861
-
项目类别:
-
资助金额:$52.6万
-
财政年份:2023
-
负责人:Yabing Chen
-
依托单位:
BLRD Research Career Scientist Award Renewal
-
批准号:10346455
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Yabing Chen
-
依托单位:
BLRD Research Career Scientist Award Renewal
-
批准号:10512066
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Yabing Chen
-
依托单位:
Molecular Regulation of Vascular Calcification in Diabetes
-
批准号:9775753
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Yabing Chen
-
依托单位:
Molecular Regulation of Vascular Calcification in Diabetes
-
批准号:10044410
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Yabing Chen
-
依托单位:
Molecular Regulation of Vascular Calcification in Diabetes
-
批准号:10515670
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Yabing Chen
-
依托单位:
Regulation of vascular smooth muscle cell function in atherosclerosis
-
批准号:9401283
-
项目类别:
-
资助金额:$53.3万
-
财政年份:2017
-
负责人:Yabing Chen
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10047283
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Yabing Chen
-
依托单位:
O-GlcNAcylation regulates vascular smooth muscle cells in diabetic vasculopathy
-
批准号:9211306
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2014
-
负责人:Yabing Chen
-
依托单位:
Death Receptor Signaling in Pancreatic Cancer: Mechanisms and Therapeutic Targets
-
批准号:8974353
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Yabing Chen
-
依托单位:
O-GlcNAcylation regulates vascular smooth muscle cells in diabetic vasculopathy
-
批准号:8613262
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2014
-
负责人:Yabing Chen
-
依托单位:
Death Receptor Signaling in Pancreatic Cancer: Mechanisms and Therapeutic Targets
-
批准号:8815003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Yabing Chen
-
依托单位:
Death Receptor Signaling in Pancreatic Cancer: Mechanisms and Therapeutic Targets
-
批准号:8633179
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Yabing Chen
-
依托单位:
O-GlcNAcylation regulates vascular smooth muscle cells in diabetic vasculopathy
-
批准号:8996569
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2014
-
负责人:Yabing Chen
-
依托单位:
Toll-like receptor signaling in pathogenesis of pulmonary hypertension
-
批准号:8391143
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Yabing Chen
-
依托单位:
Molecular Signaling in Oxidative Stress-induced Vascular Calcification
-
批准号:7581691
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2009
-
负责人:Yabing Chen
-
依托单位:
Molecular Signaling in Oxidative Stress-induced Vascular Calcification
-
批准号:8444700
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2009
-
负责人:Yabing Chen
-
依托单位:
Toll-like receptor signaling in pathogenesis of pulmonary hypertension
-
批准号:8195545
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Yabing Chen
-
依托单位:
Toll-like receptor signaling in pathogenesis of pulmonary hypertension
-
批准号:7782773
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Yabing Chen
-
依托单位:
海外基金